Dividend Talk

Dividend Talk
undefined
Jan 10, 2026 • 1h 24min

EPS #278 | Building Wealth Together: Our Community Portfolio Review | + Novo Nordisk News, Rio Tinto & Glencore Merger, Terry Smith's Annual Shareholder Letter,

In this episode of the Dividend Talk podcast, we review the performance of their Community Dividend Growth Portfolio, discuss Novo Nordisk's news, the Rio Tinto & Glencore Merger, Terry Smiths Fundsmith annual shareholder letter, and much more.And as always, they answer many questions from the community.🔥 Want a safer, more reliable dividend portfolio? Go here: (free stock card & deep dive samples) https://dividendtalk.eu/download-your-free-samples/ Stay Updated:Twitter - ⁠⁠@DividendTalk_⁠⁠Twitter - ⁠⁠@European_DGI⁠⁠Join our Facebook Community - ⁠⁠Dividend Talk Facebook Group⁠⁠Join our Discord group - https://discord.gg/nJyt9KWAB5
undefined
Jan 3, 2026 • 1h 7min

Eps 277 | 2025 Q4 Portfolio Review & Year in Dividends

In this episode of the Dividend Talk Podcast, we review our 2025 dividend portfolio performance, break down dividend income growth, and reflect on what worked (and what didn’t) for long-term dividend growth investors in Europe.We cover:2025 portfolio returns & dividend income growthCurrency impact (USD vs EUR) on dividends Biggest wins, mistakes & lessons learnedDividend reinvestment & compounding in actionTax questions, spin-offs & dividend growth trackingListener Q&A on stocks like Starbucks, Alphabet, HPQ & moreWhat we’ll do differently as dividend investors in 2026Join our premium dividend newsletter for in-depth European stock deep dives, dividend safety analysis, and long-term portfolio thinking. -> Pricing - Dividend TalkConnect with other dividend investors on ⁠⁠⁠⁠⁠Facebook ⁠⁠⁠⁠or ⁠⁠⁠⁠⁠⁠Discord⁠⁠ to share ideas, ask questions, and stay motivated.Subscribe & followNew episodes every week on dividend investing, portfolio strategy, and building long-term wealth with dividends.See you on the Inside!
undefined
Dec 26, 2025 • 1h 3min

EPS 276| 2025 Year in Review & Crazy Predictions for 2026

We wrap up 2025 with a full Dividend Talk year-in-review, reflecting on the biggest investing lessons, most discussed stocks, and the questions that mattered most to dividend growth investors.In this episode, we cover:• What worked (and didn’t) in 2025• The most talked-about stocks, including Novo Nordisk• Selling rules, position sizing, and withholding tax headaches• Dividend cuts, initiations, and flat dividends• Our bold (and fun) predictions for 2026• Listener questions, portfolio milestones, and dividend consistencyThis is a relaxed conversation about long-term dividend investing, staying consistent, and preparing your portfolio for the year ahead.Perfect listening for the Christmas break or as you plan your 2026 investing strategy.
undefined
Dec 19, 2025 • 1h 10min

Eps 275 | Dividend Withholding Tax: How Much Income Are You Losing?

In this episode of the Dividend Talk, we discuss dividend withholding tax, after-tax dividend yield, and dividend income for European investors.We explain how dividend taxes work across Europe, why tax treaties often fail in practice, and how broker choice impacts dividend compounding.Using real portfolio examples, we cover foreign dividend tax, dividend leakage, and whether reclaiming withholding tax is worth the effort for long-term dividend growth investors.Useful links: Continue the conversation with our community at ⁠⁠⁠⁠Facebook ⁠⁠⁠or ⁠⁠⁠⁠⁠Discord⁠⁠⁠⁠20 Deep Dives a Year &Library of 150 EU & US Dividend stocks at ⁠⁠⁠https://www.dividendtalk.eu
undefined
Dec 13, 2025 • 1h 12min

EPS 274 | Small & Mid Cap Investing with Heavy Moat Investments

In this episode of Dividend Talk, we’re joined by Niklas from Heavy Moat Investments for a deep dive into European small- and mid-cap investing, moats, portfolio concentration, and how to think about quality businesses when valuations get stretched.We kick things off with a packed dividend roundup, covering recent dividend hikes from Broadcom, Mastercard, Abbott Labs, Eli Lilly, WD-40, Zoetis, and more, with a strong focus on why healthcare has been so active lately. We also discuss Pfizer keeping its dividend flat, and what that signals for big pharma investors.From there, we look at one of the biggest European investing stories of the week: Aegon moving its headquarters to the US. We break down what this means for European capital markets, valuation multiples, and whether companies leaving Europe is a symptom of deeper structural issues.The core of the episode is our conversation with Niklas, where we explore:What a “moat” really means — and why moats are not staticHow he evaluates small and mid-cap European companiesWhy insider ownership matters more than market capHis approach to portfolio concentration vs diversificationHow he uses hurdle rates, expected IRR, and quality scoringWhen and why he decides to sell a stockWe also discuss several real-world examples, including:InPost and the rise of parcel locker networks across EuropeEVS Broadcast, a Belgian hidden champion in live sports technologyMensch und Maschine, Autodesk reselling, proprietary software, and dividend sustainabilityEdenred, regulation risk, shareholder yield, and why pessimism may be overdoneEurofins Scientific as a long-term compounder with strong capital allocationTo wrap up, we answer listener questions on:Story vs fundamentalsThe biggest financial red flags to watch forAI in investing and portfolio analysisThe “right” number of stocks in a portfolioSmall-cap investing in Europe vs the USAs always, this episode is for entertainment purposes only and should not be considered financial advice.Useful links: Continue the conversation with our community at ⁠⁠⁠⁠Facebook ⁠⁠or ⁠⁠⁠⁠Discord⁠⁠⁠20 Deep Dives a Year &Library of 150 EU & US Dividend stocks at ⁠⁠⁠https://www.dividendtalk.euHeavy Moat Investments | Substack
undefined
Dec 7, 2025 • 1h

EPS 273 | Our Christmas Dividend Stock list for 2025!

This week, we’re getting into the Christmas spirit… dividend investor style. 🎄Instead of toys under the tree, we’re talking  5 dividend growth stocks under the Christmas tree . And unlike the usual suspects we always seem to mention, this episode brings a fresh mix of companies we don’t discuss very often.But first, we dive into:Netflix acquiring Warner Bros. — What does it mean for streaming investors?         Magnum Ice Cream Company’s demerger from Unilever     Dividend hikes of the week — Including Morningstar, Owens Corning, Enbridge, and the Canadian banks showing their strength again.Listener questions — covering dividend safety in bear markets, cyclical stocks, owning LVMH through Christian Dior, and the data-centre boom. Then it’s time for our Christmas Wish List:Derek shares two U.S. and one European pick he discovered using screeners and Morningstar. European DGI reveals two high-quality companies he recently added to his portfolio — including one he’s dreamed of owning for years.See you on the inside!Useful links: Continue the conversation with our community at ⁠⁠⁠Facebook ⁠or ⁠⁠⁠Discord⁠⁠20 Deep Dives a Year &Library of 150 EU & US Dividend stocks at ⁠⁠⁠https://www.dividendtalk.eu
undefined
Nov 29, 2025 • 1h 21min

EPS 272 | 2026 Dividend Strategy: What Dividend Investors MUST Do Before Year-End

This week on Dividend Talk, we sit down together to look ahead to 2026 and ask a big question: is now the perfect moment to review and refine our dividend growth investing strategy?Every Friday, we chat about dividend stocks, and in this episode, we’re diving deep into planning, discipline, and staying focused when the market (and the holiday season!) tests our impulses.We kick things off with some Black Friday fun, then move into what really matters:Why now is the right time to review our 2026 dividend planHow we avoid emotional decisions during the busiest time of the yearThe latest dividend news: HPQ, LVMH, Alimentation Couche-Tard, Omnicom, real estate REITs and moreWhat falling oil prices and weak consumer trends might mean for dividend investorsInsights from Goldman Sachs and Allianz on expected European equity performanceOur biggest lessons from past years — from dividend safety to tax optimisationHow to prepare your portfolio for next year’s opportunities and risksAnd of course, your listener questions on income factory theory, REITs, AI disruption, sin stocks, and how we experience the real “snowball effect” of compoundingIf you want to continue the conversation, you can join our growing community of European dividend investors on Facebook or Discord — we’re always there sharing ideas, lessons, and motivation.See you on the inside!Useful links: Continue the conversation with our community at ⁠⁠Facebook⁠ or ⁠⁠Discord⁠⁠ 20 Deep Dives a Year &Library of 150 EU & US Dividend stocks at ⁠⁠https://www.dividendtalk.eu
undefined
Nov 22, 2025 • 1h 16min

EPS 271 |European Dividends with an AI Edge: 5 EU Stocks Getting a Tech Boost

Join us in Malmo for a real-life #DividendTalk meetup. Signup here: ⁠🔗 https://docs.google.com/forms/d/e/1FAIpQLScSSOtk8LjBL80RLgfDjA1ITL16q89IlvbErgRUsdA0KG5ahw/viewform?usp=header⁠ 📍 Location: Malmö, Sweden📅Date: Friday, 17 January 2025 Welcome to Episode 271! This week, we look past the US techgiants to find five European dividend stocks with a legitimate AI edge. Here’s what you’ll hear:The AI Bubble Debate: We discuss whether the AI bubble is about to burst, analysing warnings from Michael Burry, Palantir's Alex Karp, and Alphabet's Sundar Pichai, and contrasting them with Nvidia’s bullish stance. We also debate whether Meta’s massive infrastructure investment plan will actually pay off for shareholders. Dividend News: We cover a surprising 12.5% dividend hike and share buyback from Medical Properties Trust, as well as a massive increase from Games Workshop. We also celebrate the concept of "Dividend Overshoot Day." 5 European AI Plays: We break down five companies that benefit from the AI boom without being pure-play AI stocks. We cover the critical hardware role of ASML, the industrial automation of Siemens and Schneider Electric, the enterprise stickiness of SAP, and thedesign capabilities of Dassault Systèmes. Listener Questions: We wrap up by answering community questions on using margin Leverage, adapting Ray Dalio’s "All Weather" strategy, thoughts on Target’s current valuation, and the risks behind Johnson & Johnson’s spin-offs. Don't miss this one!Useful links: Continue the conversation with our community at ⁠Facebook⁠ or ⁠Discord⁠ 20 Deep Dives a Year &Library of 150 EU & US Dividend Stocks at ⁠https://www.dividendtalk.eu
undefined
Nov 16, 2025 • 1h 28min

EPS #270 | 3 Safe Dividend Stocks in the Nordics & Merck's $9.2 Billion Acquisition

Join us in Malmo for a real-life #DividendTalk meetup. Sign up here: 🔗 https://docs.google.com/forms/d/e/1FAIpQLScSSOtk8LjBL80RLgfDjA1ITL16q89IlvbErgRUsdA0KG5ahw/viewform?usp=header 📍 Location: Malmö, Sweden📅 Date: Saturday, 17 January 2026Welcome to Episode 270! This week, we dive into a jam-packed episode covering Merck's pharmaceutical acquisition, a European earnings report, and a dive into 3 dividend stocks from the Nordics.Here’s what you’ll hear:Big Pharma Moves: We analyze Merck's aggressive, multi-billion dollar strategy to diversify its pipeline and reduce its reliance on its flagship drug, Keytruda, by planning the $9.2 billion acquisition of Cidara Therapeutics.Earnings & Dividends: We break down Siemens' latest earnings report, the impact of their small dividend hike and the reason why. Plus, we quickly review fresh dividend increases from Deutsche Telekom, Vodafone, ADP, and AFLAC.Nordic Dividend Stocks: We explore what makes the Scandinavian region a hotbed for dividend growth and why countries like Sweden have such high retail investor participation. We then share our analysis on three safe dividend payers from the Nordics, including a look at industrial giant Atlas Copco and the high-yielding insurer Mandatum.Listener Questions: We wrap up by answering your questions on Finnish company Valmet, the latest shareholder letter from Warren Buffett, and the pros and cons of investing with fractional shares.Don't miss this one!Useful links:Continue the conversation with our community at Facebook or Discord20 Deep Dives a Year & Library of 150 EU & US Dividend Stocks at https://www.dividendtalk.eu
undefined
Nov 8, 2025 • 1h 33min

EPS #269 | Novo Nordisk Earnings, Kimberly-Clark Buys Kenvue, & Our Update on monthly dividend portfolio

In this week’s episode of Dividend Talk we kick off with Kimberly-Clark’s surprise move to buy Kenvue, asking if it’s a smart acquisition or a future balance-sheet headache. Then we review Q3 earnings from Novo Nordisk, Wolters Kluwer, and Ahold Delhaize, three European dividend powerhouses facing very different challenges.Novo Nordisk’s obesity drugs, valuation reset, and dividend safety dominate the discussion, while Wolters Kluwer’s high-PE sell-off and the impact of AI on research businesses spark debate on fair value and buybacks. We also look at Snap-on’s double-digit dividend hike and Simon Property Group’s steady income growth for REIT investors.Later, we revisit our “Monthly Dividend Portfolio” challenge from 2022, checking how picks like Altria, AbbVie, Johnson & Johnson, Realty Income, Shell, and Texas Instruments performed with lessons on dividend growth, yield, and diversification.In the listener Q&A, we cover:Dividend tax strategies and EU exit taxes How to handle rising wealth taxes as a dividend investor Fair-value analysis vs Morningstar valuations Our take on Volkswagen, General Mills, GreenCoat UK, ExxonMobil vs Chevron, and the global renewable-energy transition Thoughts on Unilever’s upcoming Magnum spinoff SEE YOU ON THE INSIDE!!Tickers discussed: KMB, KVUE, NVO, LLY, PFE, WKL.AS, AD.AS, SNAP-ON, SPG, MO, ABBV, JNJ, O, TXN, SHEL, GIS, XOM, CVX, UKW.LJoin us:[Facebook] – Https://www.facebook.com/groups/dividendtalk⁠[Twitter] – @DividendTalk_ , @European_DG[Discord] – ⁠https://discord.gg/nJyt9KWAB5⁠[Premium Services] – ⁠https://dividendtalk.eu/download-your-free-samples/⁠[Malmo Meetup] – ⁠https://t.co/STgV1nMWKj

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app